Navigation Links
Nektar Therapeutics Announces Agreement to Sell CIMZIA® and MIRCERA® Royalties to Royalty Pharma for $124 Million
Date:2/29/2012

SAN FRANCISCO, Feb. 29, 2012 /PRNewswire/ --  Nektar Therapeutics (Nasdaq: NKTR) today announced that it agreed to sell to Royalty Pharma its royalties on future sales of CIMZIA®, under Nektar's agreement with UCB Pharma, and MIRCERA®, under Nektar's agreement with Roche. In consideration for the sale, Royalty Pharma will pay Nektar an aggregate cash payment of $124.0 million.

Nektar intends to use the net proceeds of the transaction towards the repayment of its $215.0 million of convertible debt.  For the twelve month period ended December 31, 2011, Nektar recognized $8.3 million in aggregate royalties from net sales of CIMZIA® and MIRCERA®.

"This transaction demonstrates our ability to unlock unrecognized value in Nektar's legacy collaborations and access significant capital in a non-dilutive transaction," said Howard W. Robin, President and Chief Executive Officer of Nektar.  "The proceeds from this sale will strengthen our cash position considerably and we are pleased to have Royalty Pharma as our partner in this transaction."

Pablo Legorreta, Chief Executive Officer of Royalty Pharma, stated, "We are pleased to have had the opportunity to work with Nektar in this important transaction. Royalty Pharma's goal is to be the preferred financial partner to leading biopharmaceutical companies seeking to access capital from their passive royalty assets. The CIMZIA® and MIRCERA® royalties are very high quality assets that will be an excellent addition to our diversified portfolio of leading biopharmaceutical royalties."

Pursuant to the agreement entered into between Nektar and RPI Finance Trust, an affiliate of Royalty Pharma, RPI Finance Trust will receive all royalties on worldwide net sales of CIMZIA® and MIRCERA® from and after January 1, 2012.  If certain worldwide net sales thresholds for MIRCE
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Nektar Presents Positive Proof-of-Concept Clinical Data for Its New Opioid Molecule, NKTR-181, at American Academy of Pain Medicines 28th Annual Meeting
2. Nektar to Announce Financial Results for the Fourth Quarter and Year-End of 2011 on Wednesday, February 29, 2012, After Close of U.S.-Based Financial Markets
3. Positive Data for Nektars New Mu-Opioid Analgesic Molecule to Treat Acute Pain Highlighted at Neuroscience 2011
4. Nektar Therapeutics Reports Third Quarter 2011 Financial Results
5. Nektar to Announce Financial Results for the Third Quarter of 2011 on Wednesday, November 2, 2011, After Close of U.S.-Based Financial Markets
6. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the UBS 2011 Global Life Sciences Conference in New York City
7. Nektar Initiates Second Phase 1 Clinical Study Evaluating NKTR-181, A Novel Opioid Molecule, for Treatment of Chronic Pain
8. Nektar Therapeutics Reports Second Quarter 2011 Financial Results
9. Nektar to Announce Financial Results for the Second Quarter of 2011 on Thursday, August 4, 2011, After Close of U.S.-Based Financial Markets
10. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2011 Global Healthcare Conference in New York
11. Nektar Announces New Phase 2 Data for NKTR-102 to Be Presented at 2011 ASCO Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 2014 Rolta gab ... Sadara Chemical Company (Sadara) erhalten zu haben, ... des integrierten Chemiekomplexes von Sadara in Jubail ... im Wert von mehreren Millionen Dollar stellt ... dessen Wert sich ebenfalls auf mehrere Millionen ...
(Date:7/22/2014)...  Nektar Therapeutics (Nasdaq: NKTR ) will announce ... 2014 on Thursday, July 31, 2014, after the close of ... executive officer, will host a conference call to review the ... Time (PT). The press release and a ... through a link that is posted on the home page ...
(Date:7/22/2014)... 22, 2014  Edwards Lifesciences Corporation (NYSE: ... heart valves and hemodynamic monitoring, announced that Edwards, Chairman ... as an expert panelist at the invitation of the ... to discuss medical device innovation at its hearing, "21 ... Development and Communication." "Edwards has five decades ...
Breaking Medicine Technology:Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 2Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 3Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 4Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 2Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets 3Edwards' CEO Invited To Address Congress On Opportunities To Revitalize Medical Device Innovation 2
... N.C. , July 21 /PRNewswire-FirstCall / -- SPX ... completed the acquisition of the Anhydro business, a Soeborg, Denmark ... dewatering plants and equipment.  The terms of the transaction were not ... Anhydro ...
... DETROIT , July 21 Caraco Pharmaceutical ... shipping bupropion hydrochloride extended release tablets. This product was ... (FDA) for Sun Pharma,s Abbreviated New Drug Application (ANDA). ... mg, and 200 mg, are therapeutically equivalent to GlaxoSmithKline,s ...
Cached Medicine Technology:SPX Completes Acquisition of Anhydro 2SPX Completes Acquisition of Anhydro 3Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Wellbutrin SR® Extended Release Tablets 2
(Date:7/23/2014)... July 23, 2014 QueenBeeTickets.com is reducing the ... a coup for rock music fans who are still in ... buyers visit the site, they can use promo code “DISCOUNT” ... Here to view the inventory of discounted tickets at ... in August, September and October, with The Eagles concert tickets ...
(Date:7/23/2014)... Temecula Valley Southern California Wine Country, ... Wine Country artisan food and wine experiences combine ... nourishing. Savor like locals at Briar Rose, Cougar, ... EAT Marketplace, Palumbo’s Ristorante, Robin’s Nest, Old Town ... Kimberly Adams, president and CEO, Visit Temecula Valley ...
(Date:7/23/2014)... In an effort to help advance ... Disease” at the state level, the National Alliance ... of America (AFA) this week released a white ... and the need for wide-scale implementation of state plans ... The white paper outlines recommendations for both ...
(Date:7/23/2014)... living with multiple chronic medical conditions, a new study ... Health finds that the more ailments you have after ... one of the first to examine the burden of ... may help explain why increases in life expectancy among ... findings, based on an analysis of 1.4 million Medicare ...
(Date:7/22/2014)... July 23, 2014 Recently, iFitDress.com, a popular ... has announced its new selection of white party dresses ... that custom made outfits are now available on its website. ... before the end of July can get a discounted rate, ... products are popular among international customers, so its marketing specialist ...
Breaking Medicine News(10 mins):Health News:History of The Eagles Tour Tickets: QueenBeeTickets.com Reduces Prices on Remaining Inventory of Concert Tickets for 2014 Shows 2Health News:12 Artisan Food and Wine Experiences in Temecula Valley Southern California Wine County 2Health News:12 Artisan Food and Wine Experiences in Temecula Valley Southern California Wine County 3Health News:12 Artisan Food and Wine Experiences in Temecula Valley Southern California Wine County 4Health News:National Alliance for Caregiving and Alzheimer’s Foundation of America Release Joint Report to Help States Implement Alzheimer’s Plans 2Health News:National Alliance for Caregiving and Alzheimer’s Foundation of America Release Joint Report to Help States Implement Alzheimer’s Plans 3Health News:Life expectancy gains threatened as more older Americans suffer from multiple conditions 2Health News:Life expectancy gains threatened as more older Americans suffer from multiple conditions 3Health News:Elegant White Party Dresses Now Provided by Distinguished Company iFitDress.com 2
... of the AMA,board, HONOLULU, Hawaii, Nov. 13 ... Inc., has been newly elected,to the American Medical Association ... today. Mr. Kay will be the,only non-physician member on ... the position., Mr. Kay has spent his career ...
... Nov. 13 Nastech,Pharmaceutical Company Inc. ("Nastech") (Nasdaq: ... Directors has approved the recommendation of its Special,Committee ... Nastech,s,wholly-owned subsidiary, MDRNA, Inc. ("MDRNA"), as an independent ... related to,RNA interference ("RNAi") into MDRNA. The new ...
... BOTHELL, Wash., Nov. 13 Nastech,Pharmaceutical Company ... its,corporate restructuring initiatives aimed at reducing operating expenses,and ... its,subsidiary, MDRNA, Inc., as an independent, separately financed ... Phase 2 clinical and partnered,programs as well as ...
... (SWX:,ROG.VX; RO.S) confirmed today that it has entered into ... VMSI ) and that it,will commence due diligence. Roche ... with respect to the acquisition of Ventana will be,reached. ... offer to acquire all of the,outstanding common shares of ...
... of sound in medicine has a long history. Doctors have ... human body since the early 19th century, and ultrasound imaging ... the United States typically know the gender of their offspring ... pregnancy. , Now scientists are finding many more advanced applications ...
... A gene linked to pediatric brain tumors is an essential ... of Medicine in St. Louis have found. , The study, ... neurofibromatosis 1 (NF1) gene helps push stem cells down separate ... brain cells: support cells known as astrocytes and brain neurons. ...
Cached Medicine News:Health News:Fortune 500 Executive Elected to AMA Board of Trustees 2Health News:Nastech to Establish Subsidiary, MDRNA, Inc., as an Independent Company to Focus on the Development of RNA-Based Therapeutics 2Health News:Nastech to Establish Subsidiary, MDRNA, Inc., as an Independent Company to Focus on the Development of RNA-Based Therapeutics 3Health News:Nastech to Establish Subsidiary, MDRNA, Inc., as an Independent Company to Focus on the Development of RNA-Based Therapeutics 4Health News:Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs 2Health News:Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs 3Health News:Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs 4Health News:Roche Confirms Commencement of Due Diligence with Ventana 2Health News:Roche Confirms Commencement of Due Diligence with Ventana 3Health News:Roche Confirms Commencement of Due Diligence with Ventana 4Health News:Sound medicine at Acoustics Meeting 2Health News:Sound medicine at Acoustics Meeting 3Health News:Sound medicine at Acoustics Meeting 4Health News:Sound medicine at Acoustics Meeting 5Health News:Sound medicine at Acoustics Meeting 6Health News:Sound medicine at Acoustics Meeting 7Health News:Sound medicine at Acoustics Meeting 8Health News:Cancer gene drives pivotal decision in early brain development 2Health News:Cancer gene drives pivotal decision in early brain development 3
The Surgiflex WAVE XP couples the state-of-the-art Surgiflex WAVE Probe with the convenience of a truly portable battery-powered pump....
... a minimally invasive, highly effective surgical alternative ... GYNECARE TVT is positioned close to the ... when needed, TVT provides tension-free support of ... procedure takes approximately 20 to 30 minutes, ...
... best of both worlds, the PeaceKeeper ... the latest addition to the Wet-Field ... cautery instruments for ophthalmic surgery. Combining ... aspiration and backflush functionality in a ...
...
Medicine Products: